22/05/2025 20:11
|
Medical, Health & Aged Care
New data from SEQUOIA, to be reported in two oral presentations, underscore the benefits of BRUKINSA® as first-line treatment for patients with chronic lymphocytic leukemia (CLL)
Promising early...